Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | KCNE1 | P15382 | 7/20 | 0.35 |
| ▸ | KCNQ1 | P51787 | 7/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | AKT1 | P31749 | 3/20 | 0.32 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.32 |
| ▸ | TLR3 | O15455 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6602456 | 0.85 | MAPT (0.39) | MAPTKCNE1KCNQ1KCNH2MEN1 | |
| SCHEMBL6601925 | 0.85 | KCNE1 (0.44) | MAPTKCNE1KCNQ1KCNH2MEN1 | |
| SCHEMBL6604472 | 0.83 | KCNE1 (0.45) | MAPTKCNE1KCNQ1KCNH2MEN1 | |
| SCHEMBL6606045 | 0.83 | KCNE1 (0.53) | MAPTKCNE1KCNQ1KCNH2MEN1 | |
| SCHEMBL6601750 | 0.81 | KCNE1 (0.43) | MAPTKCNE1KCNQ1KCNH2MEN1 | |
| SCHEMBL6603289 | 0.81 | KCNE1 (0.44) | MAPTKCNE1KCNQ1KCNH2MEN1 | |
| SCHEMBL6604284 | 0.80 | KCNE1 (0.38) | MAPTKCNE1KCNQ1MEN1KMT2A | |
| SCHEMBL6604986 | 0.80 | HPGD (0.45) | MAPTKCNE1KCNQ1MEN1KMT2A | |
| SCHEMBL6602008 | 0.79 | KCNE1 (0.44) | MAPTKCNE1KCNQ1KCNH2MEN1 | |
| SCHEMBL7900343 | 0.79 | KCNE1 (0.43) | KCNE1KCNQ1KCNH2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0906911-B1 | Sulfonamid-substituted chromane derivatives (K+channel-blocker), process for their preparation, their use as drugsand pharmaceutical compositions containing them | AVENTIS PHARMA GMBH (DE) | 2004-04-28 | — | — | EP | disclosed |
| US-6177449-B1 | CARDIOVASCULAR DISORDERS; ANTIULCER AGENTS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-01-23 | — | — | US | disclosed |
| EP-0906911-A1 | Sulfonamid-substituted chromane derivatives (K+channel-blocker), process for their preparation, their use as drugsand pharmaceutical compositions containing them | Hoechst Marion Roussel Deutschland GmbH (DE) | 1999-04-07 | — | — | EP | disclosed |